Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Daad Sayegh is active.

Publication


Featured researches published by Daad Sayegh.


Cancer Research | 2008

AR47A6.4.2, a naked monoclonal antibody targeting Trop-2, exhibits anti-tumor efficacy in multiple human cancer models as a monotherapeutic agent and demonstrates efficacy in combination therapy

Amandine Truong; Ningping Feng; Daad Sayegh; Baldwin Mak; Susan Hahn; Daniel S. Pereira; David S. F. Young


Cancer Research | 2005

Three unique antibodies demonstrate therapeutic effects against CD63, a novel target for cancer therapy

Susan E. Hahn; Victor Saldivia; Daad Sayegh; Huma Ahmad; Lisa M. Cechetto; Luis da Cruz; D.S. Young


Cancer Research | 2006

AR53A10.11 and AR58A314.1, 2 ARIUS functional monoclonal antibodies target tumor specific antigens

Daad Sayegh; Mitra Amoozgar; Fortunata McConkey; Nives Ceric; Susan E. Hahn; Helen P. Findlay; David S. Young


Molecular Cancer Therapeutics | 2007

AR47A6.4.2, a functional naked monoclonal antibody targeting Trop-2, demonstrates in vivo efficacy in human pancreatic, colon, breast and prostate cancer models

Amandine Truong; Ningping Feng; Daad Sayegh; Baldwin Mak; Kevin O'Reilly; Sui-Wah Fung; Nives Ceric; Susan Hahn; Daniel S. Pereira; Helen P. Findlay; David S. Young


Archive | 2008

Zytotoxizitätsvermittlung von zellen mit cd44-oberflächenexpression

David S. F. Young; Daad Sayegh; Sheung T. Fan; Ronnie Tung-Ping Poon; Trence Kin Wah Lee


Ejc Supplements | 2008

521 POSTER A monoclonal antibody targeting the breast cancer stem cell marker melanoma-associated chondroitin sulfate proteoglycan improves survival and demonstrates anti-tumor activity in vivo

Ashwani K. Gupta; Alison L. Ferry; Mitra Amoozgar; Carlos Alexandre Vieira; Daad Sayegh; J. Menendez; N. Ceric; L.A.G. da Cruz; Daniel S. Pereira; D.S. Young


Archive | 2007

Médiation de cytotoxicité de cellules attestant d'une expression superficielle de cd63

Luis A. G. Dacruz; Sheung T. Fan; Helen P. Findlay; Susan E. Hahn; Terence Kin-Wah Lee; Ronnie Tung-Ping Poon; Daad Sayegh; David S. F. Young


Archive | 2007

Anticorps 141205-02 modifiant les maladies cancéreuses

David S. F. Young; Helen P. Findlay; Susan E. Hahn; Lisa M. Cechetto; Fortunata McConkey; Daad Sayegh


Molecular Cancer Therapeutics | 2007

A monoclonal antibody targeting melanoma-associated chondroitin sulfate proteoglycan demonstrates antitumor activity in human melanoma, ovarian and breast cancer models.

Ashwani K. Gupta; Alison L. Ferry; Daad Sayegh; Luis da Cruz; Ningping Feng; Susan Hahn; Daniel S. Pereira; Helen P. Findlay; David S. F. Young


Molecular Cancer Therapeutics | 2007

Identification and characterization of an antibody to the CD9 tetraspanin: Therapeutic implications for cancer treatment.

Javier Menendez; Daad Sayegh; Ningping Feng; Alison L. Ferry; Kevin O'Relly; Nives Ceric; Ashwani K. Gupta; Tejal B. Vyas; Susan Hahn; Daniel S. Pereira; Helen P. Findlay; David S. F. Young

Collaboration


Dive into the Daad Sayegh's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

D.S. Young

University of Hong Kong

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Luis da Cruz

University of Hong Kong

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge